Gene-Drive Technology To Control Malaria ‘Must Be Carefully Managed’

STAT: Gene-drive technology must be developed in a safe, ethical way
Anthony A. James, professor of microbiology and molecular genetics at the University of California, Irvine, School of Medicine and professor of molecular biology and biochemistry at the UCI School of Biological Sciences

“…While the potential to control malaria through genetic manipulation represents an opportunity to make significant advances in eradicating the disease, developing a technology designed to spread new genes through populations must be carefully managed. Any new tools must be as safe as they are effective. … The best way to ensure that gene-drive technology is developed safely is to discuss it openly — in laboratories, within governments, and in public. Engaging nonprofit organizations like the Foundation for the National Institutes of Health contributes to safeguarding public interest in this emerging disease-fighting tool. With so many people suffering from malaria every year, we cannot afford to leave this potential new tool unexplored. But we must do it the right way” (7/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.